# Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

> **NCT00332553** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 150 (—)

## Conditions studied

- Vasomotor Symptoms
- Endometrial Safety

## Interventions

- **DRUG:** Raloxifene
- **DRUG:** medroxyprogesterone acetate
- **DRUG:** estrogen
- **DRUG:** 17 beta estradiol

## Key facts

- **NCT ID:** NCT00332553
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 150 (—)
- **Last updated:** 2007-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332553, "Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00332553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*